[Form 4] C4 Therapeutics, Inc. Insider Trading Activity
Rhea-AI Filing Summary
C4 Therapeutics form 4 disclosure: A company director, Kenneth Carl Anderson, acquired 5,349 shares of C4 Therapeutics common stock as compensation in lieu of cash, at a price equal to the stock's closing market price of $2.15 on the transaction date. After the issuance, the reporting person directly beneficially owns 140,574 shares and reports additional indirect holdings through trusts and a spouse totaling multiple separate share blocks: 47,316 (spouse), 61,265 (2016 GRAT), 61,265 (spouse's 2016 GRAT), 16,939 (2015 irrevocable trust), and 16,939 (spouse's 2015 irrevocable trust). The filing states these trust-held shares are disclaimed except to the extent of pecuniary interest. The acquisition was made under the issuer's Non-Employee Director Compensation Policy, reflecting an election to take equity instead of cash for board service.
Positive
- None.
Negative
- None.
Insights
Director received equity compensation, increasing direct holdings by 5,349 shares at $2.15.
This Form 4 shows a routine equity grant under the company's Non-Employee Director Compensation Policy where the reporting director elected stock in lieu of cash. The transaction increases the director's direct stake to 140,574 shares and documents multiple indirect holdings through trusts and a spouse, which are disclaimed except for pecuniary interest.
For governance observers, the filing confirms director alignment through equity-based pay and documents the legal ownership structure used for estate and financial planning; the amounts disclosed are factual and there are no derivative or disposals reported.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 5,349 | $2.15 | $12K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer. The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on October 1, 2025. Shares held by the Kenneth C. Anderson 2016 Grantor Retained Annuity Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Shares held by the Cynthia E. Anderson 2016 Grantor Retained Annuity Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Shares held by the Kenneth C. Anderson 2015 Irrevocable Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Shares held by the Cynthia E. Anderson 2015 Irrevocable Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
